Cameron Doerksen
Cameron Doerksen is an analyst at National Bank Financial who recently adjusted his target price for Andlauer Healthcare Group Inc., expressing confidence in the company’s market position and growth prospects for 2025.
Not in the pool (under ¢1).
Recent news mentions
Cameron Doerksen is a National Bank analyst who provided insights on BRP's financial performance.
BRP restores financial outlook, expects major profit hit amid U.S. tariff changes
Canada· 2026-05-28
Cameron Doerksen is a National Bank Financial analyst who expressed a positive outlook on Bombardier shares.
Amber Kanwar’s Weekly Setup: What to watch for in Shopify, Bombardier and Canadian lifeco earningsCanada· 2026-02-09
Cameron Doerksen noted that Mr. Le Vot's experience makes him highly qualified for the role.
BRP picks Renault executive Denis Le Vot for CEO roleCanada· 2025-12-16
National Bank’s Cameron Doerksen maintained an outperform rating for Bombardier shares.
Friday’s analyst upgrades and downgradesCanada· 2025-08-02
National Bank Financial analyst Cameron Doerksen warns risks remain for both Canadian National Railway Co. and Canadian Pacific Kansas City Ltd.
Wednesday’s analyst upgrades and downgradesCanada· 2025-07-10
Cameron Doerksen is a National Bank analyst who believes CAE has a meaningful opportunity to streamline its operations.
CAE names Northrop Grumman executive Matthew Bromberg as next CEOCanada· 2025-06-03
National Bank of Canada analyst Cameron Doerksen has said BRP is the corporation 'most at risk' from tariffs among the transportation and industrial companies he researches.
Ski-Doo maker BRP reports quarterly loss, beats estimates, suspends financial forecasts for yearCanada· 2025-03-26
National Bank Financial analyst Cameron Doerksen sees the threat of a trade war already weighing on sentiment for BRP Inc.
Tuesday’s analyst upgrades and downgradesCanada· 2025-02-25
National Bank’s Cameron Doerksen raised his Andlauer Healthcare Group Inc. target to $49 from $45.
Tuesday’s analyst upgrades and downgradesCanada· 2025-02-11
